Literature DB >> 16651049

Revisiting hereditary hemochromatosis: current concepts and progress.

Andrew W Yen1, Tonya L Fancher, Christopher L Bowlus.   

Abstract

Originally regarded as a rare affliction notable for its distinctive evolution to "bronze diabetes," hereditary hemochromatosis is now recognized as the most common genetic disorder in populations of European ancestry. Recent advances in our understanding of iron metabolism, the identification of the gene responsible for hemochromatosis, and large epidemiologic studies have changed the diagnostic approach toward patients with hereditary hemochromatosis and other forms of iron overload. This article reviews the pathophysiology, epidemiology, clinical features, diagnostic testing, and management of hemochromatosis for the primary care provider.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651049     DOI: 10.1016/j.amjmed.2005.10.041

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  The diagnosis and management of hereditary haemochromatosis.

Authors:  Paul Clark; Laurence J Britton; Lawrie W Powell
Journal:  Clin Biochem Rev       Date:  2010-02

2.  Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis.

Authors:  Tatjana Sundic; Tor Hervig; Signe Hannisdal; Jörg Assmus; Rune J Ulvik; Richard W Olaussen; Sigbjørn Berentsen
Journal:  Blood Transfus       Date:  2013-10-23       Impact factor: 3.443

3.  MEDWISE: an innovative public health information system infrastructure.

Authors:  Yasar Guneri Sahin; Ufuk Celikkan
Journal:  J Med Syst       Date:  2010-11-26       Impact factor: 4.460

Review 4.  All patients with 'idiopathic' hypopituitarism should be screened for hemochromatosis.

Authors:  Anthony S Lewis; C Hamish Courtney; A Brew Atkinson
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

5.  Phenotypic characteristics and diagnoses of patients referred to an iron overload clinic.

Authors:  John B Dever; Mark A Mallory; Julie E Mallory; Dorothy Wallace; Kris V Kowdley
Journal:  Dig Dis Sci       Date:  2009-12-24       Impact factor: 3.199

6.  Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis.

Authors:  Subhashini Chandrasekharan; Emily Pitlick; Christopher Heaney; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

7.  Effects of Iron Overload on the Activity of Na,K-ATPase and Lipid Profile of the Human Erythrocyte Membrane.

Authors:  Leilismara Sousa; Israel J P Garcia; Tamara G F Costa; Lilian N D Silva; Cristiane O Renó; Eneida S Oliveira; Cristiane Q Tilelli; Luciana L Santos; Vanessa F Cortes; Herica L Santos; Leandro A Barbosa
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

Review 8.  Body iron metabolism and pathophysiology of iron overload.

Authors:  Yutaka Kohgo; Katsuya Ikuta; Takaaki Ohtake; Yoshihiro Torimoto; Junji Kato
Journal:  Int J Hematol       Date:  2008-07-02       Impact factor: 2.490

Review 9.  Iron metabolism: current facts and future directions.

Authors:  Leida Tandara; Ilza Salamunic
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

10.  Population-based analysis of the frequency of HFE gene polymorphisms: Correlation with the susceptibility to develop hereditary hemochromatosis.

Authors:  Martha-Spyridoula Katsarou; Rosana Latsi; Maria Papasavva; Nikolaos Demertzis; Thodoris Kalogridis; Aristides M Tsatsakis; Demetrios A Spandidos; Nikolaos Drakoulis
Journal:  Mol Med Rep       Date:  2016-05-20       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.